If you have been reading about TB-500 and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-04-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
Material sold under this label typically arrives as a freeze-dried powder in a sealed vial with a certificate of analysis. Such certificates usually report reversed-phase chromatography purity plus a mass confirmation, and stated purities commonly sit between 95 and 99 percent. Counter-ion identity, residual trifluoroacetate, water content, and peptide net weight are separate specifications that a certificate may or may not include. A purity figure alone does not establish sequence identity, so independent mass verification remains the practical check.
The designation TB-500 circulates in laboratory and catalog contexts without a single agreed definition. Most product listings apply it to an N-terminally acetylated seven-residue fragment of thymosin beta-4, while other listings attach the same label to the full 43-residue protein. Because the term is commercial rather than systematic, two entries bearing identical names may describe different molecules. Any documentation should therefore state which sequence a given sample is claimed to contain.
The fragment most often associated with the name carries the sequence Ac-LKKTETQ, matching residues 17 through 23 of thymosin beta-4. That region holds the actin-binding motif responsible for much of the parent protein's biochemical activity. Apart from N-terminal acetylation the peptide is unmodified and contains no disulfide bonds, so it shows little ordered secondary structure in solution. Full-length thymosin beta-4 is instead a 43-residue polypeptide of roughly 4.9 kDa found widely across mammalian cell types.
| Property | Value | Notes |
|---|---|---|
| Generic designation | Synthetic thymosin beta-4 N-terminal fragment | Peptide nomenclature varies by supplier |
| Peptide length | Approximately 17 amino acid residues | Reported length sometimes differs between sources |
| N-terminal modification | Acetyl group | Affects mass and chromatographic behaviour |
| Compound class | Small synthetic peptide | Not a small-molecule drug |
| Common synonyms | TB4 fragment; thymosin beta-4 fragment | Naming is inconsistent in popular media |
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
No major regulatory agency has approved TB-500 for therapeutic use, and it holds no pharmacopoeial monograph. The name appears on the World Anti-Doping Agency prohibited list within the class covering peptide hormones, growth factors, and related substances. Detection in doping control relies on mass spectrometric methods applied to urine, often after preparation steps that concentrate the analyte. Discussion of TB-500 therefore clusters in biochemistry, sports medicine, and anti-doping literature rather than in registered clinical trials.
TB-500 is a synthetic peptide preparation marketed under a name derived from thymosin beta-4, a 43-residue actin-binding protein first isolated from thymus tissue. The full-length protein has a reported molecular mass near 4963 Da, while material sold as TB-500 is often described as a fragment containing the actin-binding motif LKKTETQ. Because suppliers use the name inconsistently, published sources sometimes refer to the same label as a fragment, a synthetic copy, or a related analog. This naming ambiguity complicates direct comparison of reports across studies.
The Egyptians were the first to produce an artificial imitation of turquoise, in the glazed earthenware product faience. Later glass and enamel were also used, and in modern times more sophisticated porcelain, plastics, and various assembled, pressed, bonded, and sintered products (composed of various copper and aluminium compounds) have been developed: examples of the latter include "Viennese turquoise", made from precipitated aluminium phosphate colored by copper oleate; and "neolith", a mixture of bayerite and copper(II) phosphate. Most of these products differ markedly from natural turquoise in both physical and chemical properties, but in 1972, Pierre Gilson introduced one fairly close to a true synthetic (it does differ in chemical composition owing to a binder used, meaning it is best described as a simulant rather than a synthetic). Gilson turquoise is made in both a uniform color and with black "spiderweb matrix" veining not unlike the natural Nevada material. The most common imitation of turquoise encountered today is dyed howlite and magnesite, both white in their natural states, and the former also having natural (and convincing) black veining similar to that of turquoise. Dyed chalcedony, jasper, and marble is less common, and much less convincing.
Snakes were both revered and worshipped and feared by early civilizations. The ancient Egyptians recorded prescribed treatments for snakebites as early as the Thirteenth Dynasty in the Brooklyn Medical Papyrus, which includes at least seven venomous species common to the region today, such as the horned vipers. In Judaism, the Nehushtan was a pole with a snake made of copper fixed upon it. The object was regarded as a divinely empowered instrument of God that could bring healing to Jews bitten by venomous snakes while they were wandering in the desert after their exodus from Egypt. Healing was said to occur by merely looking at the object as it was held up by Moses. Historically, snakebites were seen as a means of execution in some cultures. Reportedly, in Southern Han during China's Five Dynasties and Ten Kingdoms period and in India a form of capital punishment was to throw people into snake pits, leaving people to die from multiple venomous bites. According to popular belief, the Egyptian queen Cleopatra VII committed suicide by letting herself be bitten by an asp—likely an Egyptian cobra—after hearing of Mark Antony's death, while some contemporary ancient authors rather assumed a direct application of poison. Snakebite as a surreptitious form of murder has been featured in stories such as Sir Arthur Conan Doyle's The Adventure of the Speckled Band, but actual occurrences are virtually unheard of, with only a few documented cases.
On 15 May 2025, during his presidential visit to Qatar, Trump reiterated his desire for the United States to take over the Gaza Strip and "make it a freedom zone". According to "three sources familiar with the effort", Israel and the United States were interested in resettling Gazans to either Syria, Sudan, Morocco, or the separatist Somali regions of Puntland and Somaliland. Somalia and Sudan rejected the proposal, while Puntland and Somaliland expressed willingness to enter discussions on the matter in exchange for diplomatic recognition. In May 2025, reports emerged that the Trump administration was working on a plan to permanently relocate 1 million Gazans to Libya, while offering the release of around $30 billion in funds frozen by the US since the toppling of the regime of Muammar Gaddafi in exchange for Libyan authorities agreeing to the deal. In July, Netanyahu met with Trump and reiterated support for the plan of relocating Palestinians, saying it was "free choice" if Palestinians wanted to stay or leave. The US and Israel were working to identify countries for this plan.
== Early life == Davey is of Indigenous Australian descent with tribal ancestry that can be traced to the Kokatha people in South Australia Alwyn was born to mother Lizzie, named after father Alwyn Davey and raised in Darwin, Northern Territory. Davey played his junior football in Darwin. His father died when he was eight years old. Davey moved to Adelaide to play football semi-professionally with South Adelaide in the South Australian National Football League (SANFL). Davey first attracted the attention of AFL talent scouts after the impressive first and second seasons of his brother Aaron for the Melbourne Football Club. In the 2006 pre-season, Alwyn was invited to train with his brother at Melbourne, and many believed that the club would take a chance on him. The Demons already had a crumbing forward in Aaron and many clubs were averse to drafting short players. Furthermore, by the time of the draft, Alwyn had turned 22. Most draftees are taken at just 18, making him considered old for the national draft. Most therefore had picked Alwyn Davey to be taken by Melbourne as with a rookie selection. Essendon coach Kevin Sheedy had become particularly interested in the progress of Aaron Davey and since the success of Andrew Lovett, fast indigenous players in general. Davey was drafted by the Bombers in the 3rd round of the 2006 AFL draft.
==== Russian theater siege ==== Russian Spetsnaz security forces are suspected to have used a fentanyl analogue, or derivative (suspected to be carfentanil and remifentanil), to rapidly incapacitate people in the Moscow theater hostage crisis in 2002. The siege was ended, but many hostages died from the gas after their health was severely taxed during the days-long siege. The Russian Health Minister later stated that the gas was based on fentanyl, but the exact chemical agent has not been clearly identified.
Sources: en.wikipedia.org
Many counters have two photo multiplier tubes connected in a coincidence circuit. The coincidence circuit assures that genuine light pulses, which reach both photomultiplier tubes, are counted, while spurious pulses (due to line noise, for example), which would only affect one of the tubes, are ignored. Counting efficiencies under ideal conditions range from about 30% for tritium (a low-energy beta emitter) to nearly 100% for phosphorus-32, a high-energy beta emitter. Some chemical compounds (notably chlorine compounds) and highly colored samples can interfere with the counting process. This interference, known as "quenching", can be overcome through data correction or through careful sample preparation.
=== SEIR model === For many important infections, there is a significant latency period during which individuals have been infected but are not yet infectious themselves. During this period the individual is in compartment E (for exposed).
Nurses affiliated with the New Zealand Nurses Organisation in Auckland and Whangārei commence industrial action to protest staff shortages. A member of the New Zealand Defence Force pleads guilty before a court-martial to attempted espionage on behalf of a foreign country, in the first espionage conviction in New Zealand. He is sentenced to two years' imprisonment on 20 August. 19 August: The Interislander and Bluebridge cancel several ferry sailings due to strong swells in the Cook Strait. Foreign Minister Winston Peters recalls Trevor Mallard as New Zealand ambassador to Ireland, designating Angela Hassan-Sharp as his successor. Employees of media company Stuff vote to take strike action to protest their employer's plan to split their collective bargaining agreement. 20 August: Secondary school teachers affiliated with the Post Primary Teachers' Association went on strike for a day after rejecting the Government's one percent pay rise offer. The New Zealand Cabinet agrees to draft legislation banning greyhound racing in New Zealand. 21 August: Defence Minister Judith Collins and Foreign Minister Winston Peters announce that the Government will purchase two new Airbus A321XLR jets and five MH-60R Seahawks for the New Zealand Defence Force. Carter Holt Harvey proposes closing its Eves Valley Sawmill in the Tasman District, potentially affecting 142 jobs. Airliner Jetstar admits to 20 charges of breaching the Fair Trading Act 1986 by misleading customers about compensation.
== Specialized hardware for MD simulations == Anton – A specialized, massively parallel supercomputer designed to execute MD simulations MDGRAPE – A special purpose system built for molecular dynamics simulations, especially protein structure prediction
Sources: en.wikipedia.org
It is a synthetic peptide based on a short sequence near the start of thymosin beta-4. It is supplied as a research chemical rather than as a licensed pharmaceutical product.
No. Thymosin beta-4 is the full-length protein of about forty-three amino acids, while the fragment covers only its beginning. The two are related but are not interchangeable in experimental or analytical terms.
The label is a catalogue designation that became common in non-technical discussion. Scientific papers usually refer to the fragment by sequence or as a thymosin beta-4 N-terminal peptide.
Usually not, though usage overlaps. The label most often refers to a short acetylated fragment of the parent protein, while thymosin beta-4 itself is the full 43-residue molecule. Because suppliers vary, a sequence statement is needed to settle the question for any particular lot.